Joshua Riggs
Vermögen: 178 397 $ am 31.07.2026
Vermögen: 178 397 $ am 31.07.2026
Joshua Riggs was the founder of Intelliger Consulting LLC, founded in 2015, and served as Principal from 2015 to 2020.
Mr. Riggs is currently President, Chief Executive Officer & Director at Insight Molecular Diagnostics, Inc., starting in 2023.
Former positions include Principal at Bethesda Group LLC from 2016 to 2020.
Education includes an MBA from the University of Mississippi and an undergraduate degree from Adelphi University.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 27.04.2026 | 38’365 ( 0.13% ) | 178 397 $ | 31.07.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| INSIGHT MOLECULAR DIAGNOSTICS INC. | Vorstandsvorsitzender | 01.12.2022 |
| Unternehmen | Position | Ende |
|---|---|---|
Bethesda Group
Bethesda Group Investment ManagersFinance Bethesda Group invests in companies located in the United States. The firm focuses on the biotechnology sector. It provides financing for early stage capital requirements. | Corporate Officer/Principal | 01.07.2020 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 4 |
|---|---|
Adelphi University
Adelphi University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Mississippi
University of Mississippi Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
OncoCyte Corp.
OncoCyte Corp. BiotechnologyHealth Technology Focuses on the discovery, development and commercialization of novel, non-invasive, liquid biopsy diagnostics for the early detection of cancer | Health Technology |
Bethesda Group
Bethesda Group Investment ManagersFinance Bethesda Group invests in companies located in the United States. The firm focuses on the biotechnology sector. It provides financing for early stage capital requirements. | Finance |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen